Table 3.
Authors | Clinical Predictors | Therapy Predictors | Histologic Predictors |
---|---|---|---|
De Rosa et al. (17) 2018 | Short duration of SLE at repeated kidney biopsy | Activity index >2 at repeated kidney biopsy | |
Goswami et al. (13) 2019 | Short duration of SLE at withdrawal of therapy (<8 years) | Short duration of steroid before stop (4.7 versus 6.8 yr),a no treatment with IS; only for kidney flares: lower initial dose of steroids, presence of AIHA | |
Tani et al. (12) 2019 | SLEDAI>4 at stop therapy; short time from last flare (0.93 versus 6 yr) | ||
Zen et al. (14) 2017 | Short duration of remission at stop therapy | No use of antimalarial therapy | |
Moroni et al. (10) 2013 | Short duration of remission at stop therapy (1 versus 4.4 yr) | Short duration of therapy before stop (2.6 versus 8.2 yr); no use of antimalarial therapy | |
Zen et al. (11) 2021 | Younger age at discontinuation of therapy; remission <3 yr at discontinuation of therapy | No use of antimalarials after discontinuation of therapy |
IS, immunosuppressor; AIHA, autoimmune hemolytic anemia; SLEDAI, SLE disease activity index.
The probability of not having a flare is 3.2 times lower for each additional year of steroids administered after remission activity index.